PP
DRIO icon

Paloma Partners’s DarioHealth DRIO Stock Holding History

Paloma Partners’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-630
Closed -$163K – 1879
2021
Q4 		$163K Buy
+630
New +$192K ﹤0.01% 1667

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paloma Partners's DRIO Position: Q1 2022 in Review

Paloma Partners sold out of DarioHealth (DRIO) in Q1 2022, closing a stake of 630 shares — an estimated $163K sold.

Paloma Partners first reported a position in DRIO in Q4 2021 and held it in 1 quarter. The position peaked at $163K in Q4 2021. 63 funds tracked by Wall St. Rank hold DRIO as of Q1 2022.

  • Paloma Partners reported no remaining DarioHealth position as of Q1 2022 after selling out during the quarter.
  • Paloma Partners sold 630 DarioHealth shares in Q1 2022, an estimated $163K.
  • Paloma Partners first reported a position in DarioHealth in Q4 2021 and held it in 1 quarter.
  • Paloma Partners's DarioHealth position peaked at $163K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held DarioHealth as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.